- Home
- / ProterixBio
ProterixBio
Total Funding
$90.2 M
ProterixBio Summary
Company Summary
- Overview
- ProterixBio (formerly known as BioScale) is a company that develops proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. It provides chronic care platforms to improve patient outcomes, starting with pulmonary diseases.
- Type
- Private
- Status
- Active
- Founded
- 2002
- HQ
- Billerica, MA, US | view all locations
- Website
- https://proterixbio.com/
- Cybersecurity rating
Table of Contents
Key People
Brett P. Masters, Chief Technology Officer
Charles L. Popkin, Chief Financial Officer
Edward F. Crawley, MIT and Co-Founder
